Welcome to the “news” section of our website, where you'll find all the latest publications on our advances in research (Alzheimer's, Parkinson's, Charcot's disease, etc.), our upcoming events, etc.
In a rare and early form of Alzheimer's disease, Institut du Cerveau - ICM researchers have shown that, surprisingly, connectivity between neurons increases during the initial phase of the disease. This transitional increase would correspond to a...
For the first time in humans, an imaging study shows an early and protective role of the immune cells of the brain, called " microglial " cells, in Alzheimer's disease. Teams from the Sainte-Anne Hospital Center, from the CEA, from the Saint-Antoine...
For the first time, an animal model, deficient for DEPDC5 gene, responsible for familial focal epilepsy with cortical malformations, has been generated by Stéphanie Baulac and Eric Leguern's team.
For the first time, Claire Wyart's team has shown in the zebra fish, the existence of a sensory system within the spinal cord, capable of detecting and modulating movement. Identification of other parameters that can activate this system, and thus...
Pr. Alexis Brice's team at the Brain and Spine Institute – Inserm / CNRS / UPMC, in collaboration with two international consortia has identified a new gene, VPS13C, involved in an early form of Parkinson's disease. Mutations in VPS13C lead to a loss...
The emergence of multidisciplinary, bold and innovative original research projects carried out by the Institut du Cerveau - ICM’s young talents, thanks to the Bolloré Group support, is the Institut du Cerveau - ICM's Brain Booster Challenge bet.
Grégoire Courtine is Associate Professor at the Swiss Federal Institute of Technology. He came to the Institut du Cerveau - ICM on February 1, 2016, and presented his research work on the use of new technologies to improve motor recovery after a...
Bassem Hassan’s team at VIB/KU Leuven has discovered a previously unknown mechanism that is highly conserved between species and which regulates neurogenesis through precise temporal control of the activity of a family of proteins essential for brain...
Paris Brain Institute brings together in one place patients, doctors and researchers in order to rapidly develop treatments for nerve damage and apply these to patients as soon as possible. Coming from all backgrounds and countries, the best...
Patients with fronto-temporal dementia need specific and appropriate medical care. However, this disease is still too often confused with Alzheimer's disease. Clinicians and researchers from Paris Brain Institute and from the Memory and Alzheimer's...
Fiona Doetsch is a research group leader at the Biozentrum of the University of Basel. Upon her visit at the Institut du Cerveau - ICM, she presented her work on stem cells, and more specifically, on what triggers their activation. Stem cells could...
The Institut du Cerveau - ICM scientists have recently discovered a mechanism which protects neurons from cell death. The loss of this protective mechanism may contribute to the degeneration of neurons in patients with Parkinson's disease.
